What should I do if I become drug-resistant after taking Temozolomide?

Temozolomide is a commonly used anti-cancer drug, mainly used to treat malignant glioma. However, due to long-term use or other reasons, some patients may develop drug resistance, resulting in reduced drug efficacy. Doctors will use genetic testing and molecular biology analysis to understand the patient's genotype and phenotypic characteristics, so as to tailor an individualized treatment plan. This helps to select a drug combination that is more suitable for the patient and improves treatment effectiveness.

Combining temozolomide with other drugs with different mechanisms of action can increase therapeutic efficacy and reduce the risk of resistance. For example, it can be used in combination with other chemotherapy drugs such as cisplatin, capecitabine, etc. Target the molecular targets related to temozolomide resistance. For example, targeted drugs such as PARP inhibitors can be used to interfere with the cellular DNA repair mechanism and increase the killing effect of temozolomide on tumor cells. Immunotherapy plays an important role in the treatment of malignant tumors by activating the patient's own immune system to attack tumor cells. In the treatment of temozolomide resistance, immunotherapy such as immune checkpoint inhibitors and CAR-T cell therapy can be considered. For temozolomide resistance, patients should handle it under the guidance of a doctor and communicate with the doctor.

The original drug temozolomide has been launched in China and has entered the scope of Class B medical insurance. Common specificationsThe price of 100mg*1 tablet*5 bags per box may be around 2,000 yuan. The price of generic temozolomide drugs marketed overseas is relatively low, and its pharmaceutical ingredients are basically the same as those of the original temozolomide drug. For example, the price of a box of 100mg*5 produced by a Bangladeshi pharmaceutical factory may be around a few hundred yuan (the price may fluctuate due to exchange rates).